Researchers combined advanced imaging techniques and theoretical physics to observe and explain how nanoclusters of the protein emerin form inside living cells. The study uncovers the molecular ‘rules’ driving the arrangement of emerin into nanoclusters and the mechanisms leading to their defective assembly in people with muscular dystrophy.
Categories
Recent Posts
- FDA authorizes a new liver safety biomarker relevant for Duchenne and Becker
- FDA approves new safety warning and updated prescribing information for Sarepta’s Elevidys
- Insmed’s ASCEND Study and INS1201, an Investigational Gene Therapy for Duchenne Muscular Dystrophy
- Progress Now: Immunotherapy Study Recruiting, Drug Cleared for Expanded Access, and More
- From Classroom to Courtroom: How Eric Arnold Navigated Accessibility in His Education and Career